1 Danahey DG, "p16 mutation frequency and clinical correlation in head and neck cancer" 119 : 285-288, 1999
2 Ribeiro IP, "WT1, MSH6, GATA5 and PAX5 as epigenetic oral squamous cell carcinoma biomarkers—a short report" 39 : 573-582, 2016
3 Webster JA, "Variations in stromal signatures in breast and colorectal cancer metastases" 222 : 158-165, 2010
4 White JS, "The influence of clinical and demographic risk factors on the establishment of head and neck squamous cell carcinoma cell lines" 43 : 701-712, 2007
5 Stratton MR, "The cancer genome" 458 : 719-724, 2009
6 Ross DT, "Systematic variation in gene expression patterns in human cancer cell lines" 24 : 227-235, 2000
7 Singh B, "Spectral karyotyping analysis of head and neck squamous cell carcinoma" 111 : 1545-1550, 2001
8 Van Dyke DL, "Recurrent cytogenetic abnormalities in squamous cell carcinomas of the head and neck region" 9 : 192-206, 1994
9 Coon SW, "Prognostic implications of loss of heterozygosity at 8p21 and 9p21 in head and neck squamous cell carcinoma" 111 : 206-212, 2004
10 Haluska FG, "Oncogene activation by chromosome translocation in human malignancy" 21 : 321-345, 1987
1 Danahey DG, "p16 mutation frequency and clinical correlation in head and neck cancer" 119 : 285-288, 1999
2 Ribeiro IP, "WT1, MSH6, GATA5 and PAX5 as epigenetic oral squamous cell carcinoma biomarkers—a short report" 39 : 573-582, 2016
3 Webster JA, "Variations in stromal signatures in breast and colorectal cancer metastases" 222 : 158-165, 2010
4 White JS, "The influence of clinical and demographic risk factors on the establishment of head and neck squamous cell carcinoma cell lines" 43 : 701-712, 2007
5 Stratton MR, "The cancer genome" 458 : 719-724, 2009
6 Ross DT, "Systematic variation in gene expression patterns in human cancer cell lines" 24 : 227-235, 2000
7 Singh B, "Spectral karyotyping analysis of head and neck squamous cell carcinoma" 111 : 1545-1550, 2001
8 Van Dyke DL, "Recurrent cytogenetic abnormalities in squamous cell carcinomas of the head and neck region" 9 : 192-206, 1994
9 Coon SW, "Prognostic implications of loss of heterozygosity at 8p21 and 9p21 in head and neck squamous cell carcinoma" 111 : 206-212, 2004
10 Haluska FG, "Oncogene activation by chromosome translocation in human malignancy" 21 : 321-345, 1987
11 Kearney L, "Multiplex-FISH(M-FISH) : technique, developments and applications" 114 : 189-198, 2006
12 Jin C, "Molecular cytogenetic characterization of the 11q13 amplicon in head and neck squamous cell carcinoma" 115 : 99-106, 2006
13 Squire JA, "Molecular cytogenetic analysis of head and neck squamous cell carcinoma : by comparative genomic hybridization, spectral karyotyping, and expression array analysis" 24 : 874-887, 2002
14 Ottaviano L, "Molecular characterization of commonly used cell lines for bone tumor research : a trans-European EuroBoNet effort" 49 : 40-51, 2010
15 Rodrigo JP, "MYC amplification in squamous cell carcinomas of the head and neck" 122 : 504-507, 1996
16 Parikh RA, "Loss of distal 11q is associated with DNA repair deficiency and reduced sensitivity to ionizing radiation in head and neck squamous cell carcinoma" 46 : 761-775, 2007
17 Pearlstein RP, "Loss of 18q predicts poor survival of patients with squamous cell carcinoma of the head and neck" 21 : 333-339, 1998
18 Summerer I, "Integrative analysis of the microRNA-mRNA response to radiochemotherapy in primary head and neck squamous cell carcinoma cells" 16 : 654-, 2015
19 Lin CJ, "Head and neck squamous cell carcinoma cell lines : established models and rationale for selection" 29 : 163-188, 2007
20 Shipitsyna E, "Guidelines for the laboratory diagnosis of Mycoplasma genitalium infections in East European countries" 90 : 461-467, 2010
21 Ribeiro IP, "Genomic predictive model for recurrence and metastasis development in head and neck squamous cell carcinoma patients" 7 : 13897-, 2017
22 Brown J, "Genomic imbalances in esophageal carcinoma cell lines involve Wnt pathway genes" 17 : 2909-2923, 2011
23 Singchat W, "Genomic alteration in head and neck squamous cell carcinoma (HNSCC) cell lines inferred from karyotyping, molecular cytogenetics, and array comparative genomic hybridization" 11 : e0160901-, 2016
24 Ribeiro IP, "Genetic imbalances detected by multiplex ligation-dependent probe amplification in a cohort of patients with oral squamous cell carcinomathe first step towards clinical personalized medicine" 35 : 4687-4695, 2014
25 Ribeiro IP, "Genetic gains and losses in oral squamous cell carcinoma: impact on clinical management" 37 : 29-39, 2014
26 Sheu JJ, "Functional genomic analysis identified epidermal growth factor receptor activation as the most common genetic event in oral squamous cell carcinoma" 69 : 2568-2576, 2009
27 van der Riet P, "Frequent loss of chromosome 9p21-22 early in head and neck cancer progression" 54 : 1156-1158, 1994
28 Borkosky SS, "Frequent deletion of ING2 locus at 4q35. 1 associates with advanced tumor stage in head and neck squamous cell carcinoma" 135 : 703-713, 2009
29 Hogg RP, "Frequent 3p allele loss and epigenetic inactivation of the RASSF1A tumour suppressor gene from region 3p21. 3 in head and neck squamous cell carcinoma" 38 : 1585-1592, 2002
30 Liehr T, "Fluorescence in situ hybridization (FISH)—application guide, vol 2" Springer 2017
31 Domcke S, "Evaluating cell lines as tumour models by comparison of genomic profiles" 4 : 2126-, 2013
32 Temam S, "Epidermal growth factor receptor copy number alterations correlate with poor clinical outcome in patients with head and neck squamous cancer" 25 : 2164-2170, 2007
33 Ribeiro I, "Cytogenetic, genomic and epigenetic characterization of HSC-3 tongue cell line, with lymphnode metastasis" 60 (60): 70-81, 2018
34 Freier K, "Cytogenetic characterization of head and neck squamous cell carcinoma cell lines as model systems for the functional analyses of tumorassociated genes" 39 : 382-389, 2010
35 Suda T, "Copy number amplification of the PIK3CA gene is associated with poor prognosis in non-lymph node metastatic head and neck squamous cell carcinoma" 12 : 416-, 2012
36 Pathare SM, "Clinicopathological and prognostic implications of genetic alterations in oral cancers" 2 : 445-451, 2011
37 Lin SC, "Chromosomal changes in betel-associated oral squamous cell carcinomas and their relationship to clinical parameters" 38 : 266-273, 2002
38 Bauer VL, "Chromosomal changes characterize head and neck cancer with poor prognosis" 86 : 1353-1365, 2008
39 Gollin SM, "Chromosomal alterations in squamous cell carcinomas of the head and neck : window to the biology of disease" 23 : 238-253, 2001
40 Kytola S, "Chromosomal alterations in 15 breast cancer cell lines by comparative genomic hybridization and spectral karyotyping" 28 : 308-317, 2000
41 Ince TA, "Characterization of twenty-five ovarian tumour cell lines that phenocopy primary tumours" 6 : 7419-, 2015
42 Gazdar AF, "Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer" 78 : 766-774, 1998
43 Edington KG, "Cellular immortality : a late event in the progression of human squamous cell carcinoma of the head and neck associated with p53alteration and a high frequency of allele loss" 13 : 254-265, 1995
44 Greshock J, "Cancer cell lines as genetic models of their parent histology : analyses based on array comparative genomic hybridization" 67 : 3594-3600, 2007
45 Heo DS, "Biology, cytogenetics, and sensitivity to immunological effector cells of new head and neck squamous cell carcinoma lines" 49 : 5167-5175, 1989
46 Bockmuhl U, "Association of 8p23 deletions with poor survival in head and neck cancer" 124 : 451-455, 2001
47 Douglas EJ, "Array comparative genomic hybridization analysis of colorectal cancer cell lines and primary carcinomas" 64 : 4817-4825, 2004
48 Sticht C, "Amplification of Cyclin L1 is associated with lymph node metastases in head and neck squamous cell carcinoma(HNSCC)" 92 : 770-774, 2005